Histidine-rich Ca binding protein: a regulator of sarcoplasmic reticulum calcium sequestration and cardiac function

Journal of Molecular and Cellular Cardiology

Volumn 40, Issue 5, 2006, Pages 653-665

  Gregory, Kimberly N ^a   Ginsburg, Kenneth S ^b   Bodi, Ilona ^c   Hahn, Harvey ^a   Marreez, Yehia M A ^a   Song, Qiujing ^b   Padmanabhan, Prabhu A ^d   Mitton, Bryan A ^a   Waggoner, Jason R ^a   Del Monte, Federica ^d   Park, Woo Jin ^e   Dorn II, Gerald W ^a   Bers, Donald M ^b   Kranias, Evangelia G ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

^c UNIVERSITY OF CINCINNATI   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e Gwangju Institute of Science and Technology (GIST)   (South Korea)

Author keywords

Calcium cycling; Calcium uptake; Heart failure; Histidine rich calcium binding protein; Sarcoplasmic reticulum

Indexed keywords

CALCIUM BINDING PROTEIN; CALCIUM CHANNEL; CALCIUM CHANNEL L TYPE; CALCIUM ION; CELL PROTEIN; HISTIDINE; HISTIDINE RICH CALCIUM BINDING PROTEIN; REGULATOR PROTEIN; TRIADIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CALCIUM METABOLISM; CALCIUM SIGNALING; CALCIUM TRANSPORT; CELL REGENERATION; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DENSITY; DETERIORATION; HEART FUNCTION; HEART HEMODYNAMICS; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE CELL; HUMAN; HUMAN TISSUE; HYPOTHESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; SARCOPLASMIC RETICULUM; SODIUM CALCIUM EXCHANGE; TRANSGENIC MOUSE;

ANIMALS; AORTA; CALCIUM; CALCIUM CHANNELS, L-TYPE; CALCIUM-BINDING PROTEINS; HEART; MALE; MICE; MICE, TRANSGENIC; MYOCARDIUM; MYOCYTES, CARDIAC; PROMOTER REGIONS (GENETICS); SARCOPLASMIC RETICULUM;

ANIMALIA; MUS MUSCULUS;

EID: 33646093733     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2006.02.003     Document Type: Article

References (33)

1. Ho K.K., Pinsky J.L., Kannel W.B., and Levy D. The epidemiology of heart failure: the Framingham Study. J. Am. Coll. Cardiol. 22 (1993) 6A-13A
2. Francis G.S. Pathophysiology of chronic heart failure. Am. J. Med. 110 Suppl 7A (2001) 37S-46S
3. Houser S.R., Piacentino III V., and Weisser J. Abnormalities of calcium cycling in the hypertrophied and failing heart. J. Mol. Cell. Cardiol. 32 (2000) 1595-1607
4. Koss K.L., and Kranias E.G. Phospholamban: a prominent regulator of myocardial contractility. Circ. Res. 79 (1996) 1059-1063
5. Zhang L., Kelley J., Schmeisser G., Kobayashi Y., and Jones L. Complex formation between junctin, triadin, calsequestrin, and the ryanodine receptor. J. Biol. Chem. 272 (1997) 23389-23397
6. 2+ and plasma lipoproteins. J. Biol. Chem. 264 (1989) 8260-8270
7. Lee H.G., Kang H., Kim D.H., and Park W.J. Interaction of HRC (histidine-rich Ca(2+)-binding protein) and triadin in the lumen of sarcoplasmic reticulum. J. Biol. Chem. 276 (2001) 39533-39538
8. Sacchetto R., Damiani E., Turcato F., Nori A., and Margreth A. Ca(2+)-dependent interaction of triadin with histidine-rich Ca(2+)-binding protein carboxyl-terminal region. Biochem. Biophys. Res. Commun. 289 (2001) 1125-1134
9. Sacchetto R., Turcato F., Damiani E., and Margreth A. Interaction of triadin with histidine-rich Ca(2+)-binding protein at the triadic junction in skeletal muscle fibers. J. Muscle Res. Cell Motil. 20 (1999) 403-415
10. Fan G.C., Gregory K.N., Zhao W., Park W.J., and Kranias E.G. Regulation of myocardial function by histidine-rich, calcium-binding protein. Am. J. Physiol. Heart Circ. Physiol. 287 (2004) H1705-H1711
11. Kim E., Shin D.W., Hong C.S., Jeong D., Kim Do H., and Park W.J. Increased Ca(2+) storage capacity in the sarcoplasmic reticulum by overexpression of HRC (histidine-rich Ca(2+) binding protein). Biochem. Biophys. Res. Commun. 300 (2003) 192-196
12. Kranias E.G., Schwartz A., and Jungmann R.A. Characterization of cyclic 3′:5′-amp-dependent protein kinase in sarcoplasmic reticulum and cytosol of canine myocardium. Biochim. Biophys. Acta 709 (1982) 28-37
13. World Medical Association Declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects. Cardiovasc. Res. 35 (1997) 2-3
14. Harrer J.M., Kiss E., and Kranias E.G. Application of the immunoblot technique for quantitation of protein levels in cardiac homogenates. Biotechniques 18 (1995) 995-998
15. Chu G., Li L., Sato Y., Harrer J.M., Kadambi V.J., Hoit B.D., et al. Pentameric assembly of phospholamban facilitates inhibition of cardiac function in vivo. J. Biol. Chem. 273 (1998) 33674-33680
16. Chu G., Dorn II G.W., Luo W., Harrer J.M., Kadambi V.J., Walsh R.A., et al. Monomeric phospholamban overexpression in transgenic mouse hearts. Circ. Res. 81 (1997) 485-492
17. 2+-release channel: activation by caffeine. Am. J. Physiol. 256 (1989) H328-H333
18. Weber A., and Herz R. The relationship between caffeine contracture of intact muscle and the effect of caffeine on reticulum. J. Gen. Physiol. 52 (1968) 750-759
19. Bassani J.W., Bassani R.A., and Bers D.M. Relaxation in rabbit and rat cardiac cells: species-dependent differences in cellular mechanisms. J. Physiol. 476 (1994) 279-293
20. Hove-Madsen L., and Bers D.M. Passive Ca buffering and SR Ca uptake in permeabilized rabbit ventricular myocytes. Am. J. Physiol. 264 (1993) C677-C686
21. Solaro R.J., and Briggs F.N. Estimating the functional capabilities of sarcoplasmic reticulum in cardiac muscle. Calcium binding. Circ. Res. 34 (1974) 531-540
22. Luo W., Grupp I.L., Harrer J., Ponniah S., Grupp G., Duffy K., et al. Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of beta-agonist stimulation. Circ. Res. 75 (1994) 401-409
23. Harrer J.M., Haghighi K., Kim H.W., Ferguson D.G., and Kranias E.G. Coordinate regulation of SR Ca(2+)-ATPase and phospholamban expression in developing murine heart. Am. J. Physiol. 272 (1997) H57-H66
24. Petrashevskaya N.N., Bodi I., Rubio M., Molkentin J.D., and Schwartz A. Cardiac function and electrical remodeling of the calcineurin-overexpressed transgenic mouse. Cardiovasc. Res. 54 (2002) 117-132
25. Hoit B.D., Khoury S.F., Kranias E.G., Ball N., and Walsh R.A. In vivo echocardiographic detection of enhanced left ventricular function in gene-targeted mice with phospholamban deficiency. Circ. Res. 77 (1995) 632-637
26. D'Angelo D.D., Sakata Y., Lorenz J.N., Boivin G.P., Walsh R.A., Liggett S.B., et al. Transgenic G q overexpression induces cardiac contractile failure in mice. Proc. Natl. Acad. Sci. USA 94 (1997) 8121-8126
27. Dorn II G.W., Robbins J., Ball N., and Walsh R.A. Myosin heavy chain regulation and myocyte contractile depression after LV hypertrophy in aortic-banded mice. Am. J. Physiol. 267 (1994) H400-H405
28. Bers D.M. Cardiac excitation-contraction coupling. Nature 415 (2002) 198-205
29. 2+ handling and leads to a blunted contractile response to beta-adrenergic agonists. Cardiovasc. Res. 62 (2004) 122-134
30. 2+ homeostasis and cardiomyocyte function. J. Biol. Chem. 275 (2000) 38073-38080
31. 2+-ATPase isoform 2 (SERCA2) gene. J. Biol. Chem. 274 (1999) 2556-2562
32. Hasenfuss G., and Pieske B. Calcium cycling in congestive heart failure. J. Mol. Cell. Cardiol. 34 (2002) 951-969
33. Haghighi K., Gregory K.N., and Kranias E.G. Sarcoplasmic reticulum Ca-ATPase-phospholamban interactions and dilated cardiomyopathy. Biochem. Biophys. Res. Commun. 322 (2004) 1214-1222